Table 2 Hematologic profiling of blood and bone marrows in WT, B4galt1−/−, Itgb1PF4+, and B4galt1−/−Itgb1PF4+ mice.
Parameter | WT | B4galt1−/− | Itgb1PF4+ | B4galt1−/−Itgb1PF4+ |
|---|---|---|---|---|
Peripheral blood cells (6–8 weeks) | ||||
RBCs (106/µl) | 8.6 ± 0.9 | 7.7 ± 0.5 | 8.1 ± 0.5 | 6.5 ± 0.6* |
Neutrophils (K/µl) | 0.9 ± 0.1 | 4.0 ± 0.7*** | 0.6 ± 0.1 | 3.5 ± 1.0** |
Lymphocytes (K/µl) | 8.6 ± 0.8 | 10.2 ± 1.3 | 7.4 ± 0.8 | 11.4 ± 2.7 |
Monocytes (K/µl) | 1.5 ± 0.2 | 2.5 ± 0.5 | 1.7 ± 0.3 | 3.5 ± 0.8* |
Platelets (K/µl) | 893 ± 36 | 199 ± 39*** | 990 ± 9 | 551 ± 29*** |
Platelet half-life (h) | 63.2 ± 2 | 66.7 ± 5 | n.a. | n.a. |
Plasma TPO (pg/ml) | 87.9 ± 5.5 | 328.5 ± 28.8*** | n.a | n.a |
Spleen | ||||
mg/g | 3.4 ± 0.2 | 6.9 ± 1.1** | n.a. | n.a. |
Megakaryocytes/field | 1.4 ± 0.2 | 4 ± 0.8** | n.a. | n.a. |
LT-HSC (%) | 0.0018 ± 0.0007 | 0.006 ± 0.003 | n.a. | n.a. |
ST-HSC | 0.003 ± 0.001 | 0.003 ± 0.001 | n.a. | n.a. |
MPP | 0.03 ± 0.006 | 0.16 ± 0.09 | n.a. | n.a. |
Bone marrow megkaryocytes | ||||
MK (% of live cells) | 1.5 ± 0.1 | 5.6 ± 1.4* | ||
GPIbα (MFI) | 308.3 ± 24.6 | 244.4 ± 46.0 | n.a. | n.a. |
GPIbβ (MFI) | 316.4 ± 5.1 | 319.0 ± 10.8 | n.a. | n.a. |
GPIX (MFI) | 322.1 ± 10.2 | 326.8 ± 13.9 | n.a. | n.a. |
αIIb (MFI) | 326.0 ± 46.2 | 298.5 ± 37.7 | n.a. | n.a. |
β3 (MFI) | 145.1 ± 11.4 | 165.4 ± 30.1 | n.a. | n.a. |
β1 (MFI) | 467.3 ± 34.6 | 581.2 ± 25.5* | n.a. | n.a. |
CXCR4 (MFI) | 135.9 ± 12.05 | 159.2 ± 17.34 | n.a. | n.a. |
Primary transplant (% GFP+ bone marrow cells) | ||||
MK | 0.07 ± 0.002 | 0.4 ± 0.08* | n.a. | n.a. |
CD3+ | 2.6 ± 0.3 | 0.8 ± 0.2** | n.a. | n.a. |
B220+ | 11.6 ± 1.7 | 0.8 ± 0.2*** | n.a. | n.a. |
CD11b+ | 80.2 ± 2.9 | 95.2 ± 0.8** | n.a. | n.a. |
GPIbα (BM MKs, MFI) | 339.8 ± 31.2 | 317.7 ± 37.6 | n.a. | n.a. |
β3 (BM MKs, MFI) | 160.3 ± 1.8 | 173.4 ± 2.6 | n.a. | n.a. |